Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow Percutaneous Left Ventricular Support Device (SHIELD II)
ClinicalTrials.gov NCT02468778
Research payments
$531,719
Through program year 2020, $531,719 in research payments was reported against Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow Percutaneous Left Ventricular Support Device (SHIELD II), across 296 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- NCT02468778
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $531,719 | 296 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Robert Pyo Bronx, NY Named on 29 payments
- Peter Monteleone Austin, TX Named on 12 payments
- David Lasorda Pittsburgh, PA Named on 11 payments
- Samin Sharma New York, NY Named on 10 payments
- Scott Lilly Columbus, OH Named on 9 payments
- David Rizik Scottsdale, AZ Named on 8 payments
- George Chrysant Oklahoma City, OK Named on 7 payments
- Leway Chen Rochester, NY Named on 7 payments
- Andrew Civitello Houston, TX Named on 7 payments
- Saad Ahmad Cincinnati, OH Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.